2023/24 will be somewhat gloomy
20/11/23 -"We have done a first round of data integration and adjustments to our figures as the annual report will be released in a few days. 2022/23 was helped by the better operating performance in Imaging ..."
Pages
66
Language
English
Published on
20/11/23
You may also be interested by these reports :
19/01/26
Drägerwerk has delivered solid FY25 preliminary numbers. The key surprise was EBIT, which beat consensus by c.18%, reflecting better gross margins ...
15/01/26
In late-2024, when we last teased the story of DiaSorin (BUY; Italy), a family-owned in-vitro diagnostic company specialising in immunodiagnostics ...
07/01/26
Yesterday, Meta announced a delay in the international rollout of the Ray-Ban display smart glasses. The market reacted positively to this news, on ...
30/12/25
Despite revising our estimates and target price downward, DiaSorin remains a compelling investment opportunity. This is underpinned by strong ...